- Home
- IHT vs RDHL Comparison
IHT vs RDHL Comparison
Compare IHT & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- RDHL
- Stock Information
- Founded
- IHT 1971
- RDHL 2009
- Country
- IHT United States
- RDHL Israel
- Employees
- IHT N/A
- RDHL N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- RDHL Health Care
- Exchange
- IHT Nasdaq
- RDHL Nasdaq
- Market Cap
- IHT 18.0M
- RDHL 8.6M
- IPO Year
- IHT N/A
- RDHL N/A
- Fundamental
- Price
- IHT $2.28
- RDHL $6.50
- Analyst Decision
- IHT
- RDHL
- Analyst Count
- IHT 0
- RDHL 0
- Target Price
- IHT N/A
- RDHL N/A
- AVG Volume (30 Days)
- IHT 2.5K
- RDHL 21.6K
- Earning Date
- IHT 12-31-2024
- RDHL 01-03-2025
- Dividend Yield
- IHT 0.88%
- RDHL N/A
- EPS Growth
- IHT N/A
- RDHL N/A
- EPS
- IHT N/A
- RDHL N/A
- Revenue
- IHT $7,692,305.00
- RDHL $3,707,000.00
- Revenue This Year
- IHT N/A
- RDHL $224.90
- Revenue Next Year
- IHT N/A
- RDHL $82.69
- P/E Ratio
- IHT N/A
- RDHL N/A
- Revenue Growth
- IHT 4.55
- RDHL N/A
- 52 Week Low
- IHT $1.22
- RDHL $6.00
- 52 Week High
- IHT $2.36
- RDHL $40.50
- Technical
- Relative Strength Index (RSI)
- IHT 59.17
- RDHL 38.21
- Support Level
- IHT $2.06
- RDHL $6.00
- Resistance Level
- IHT $2.24
- RDHL $7.30
- Average True Range (ATR)
- IHT 0.13
- RDHL 0.51
- MACD
- IHT -0.00
- RDHL -0.09
- Stochastic Oscillator
- IHT 100.00
- RDHL 21.10
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.